PharmiWeb.com - Global Pharma News & Resources
24-Jan-2019

Incyte to Report Fourth Quarter and Year-end Financial Results

Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2018 financial results conference call and webcast for 8:00 a.m. ET on Thursday, February 14, 2019.

The schedule for the press release and conference call/webcast is as follows:

       
  • Q4 & YE 2018 Press Release:
February 14, 2019 at 7:00 a.m. ET
  • Q4 & YE 2018 Conference Call:
February 14, 2019 at 8:00 a.m. ET
  • Domestic Dial-In Number:

877-407-3042

  • International Dial-In Number:

201-389-0864

  • Conference ID Number:
13686537
 

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is +1-201-612-7415. To access the replay you will need the conference ID number 13686537.

The live webcast with slides can be accessed at www.incyte.com under For Investors, Events and Presentations and will be available for replay for 30 days.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's website at www.incyte.com.

Follow @Incyte on Twitter at https://twitter.com/Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190124005001/en/

Editor Details

Last Updated: 24-Jan-2019